Skip to main content

Health and medicine/Diseases and disorders/Cancer/Metastasis

The technique accurately predicted relapse in 12 of 15 patients about eight months before their tumors were spotted by conventional imaging.
Li Ma studies the molecular determinants of breast cancer progression, while Jeffrey Tyner is screening the genome for cancer drug targets.